FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

Explosive House report exposes failures it says allowed Epstein’s abuse to continue for years

GOP lawmaker ousts fellow Republican in gerrymandered California district

When the Pharmacies Are Empty and the Clinic Is Closed, Here’s the Kit Americans Keep Ready

Texas’ Democrat governor-elect has vowed to impose ‘emergency’ day-one policy and more top headlines

‘SNL’ writer’s sister vanished — now her boyfriend and rival face charges in deadly love triangle

Trump defends Pentagon chief as Massie targets him: ‘Hegseth should be praised, not impeached’

Reporter’s Notebook: House leadership up for grabs as GOP reckons with devastating losses

Thune forges ahead with leadership elections despite calls for post-midterm reckoning

Somali daycare CEO tied to fraud scandal wins Minnesota House seat

Trump calls on Senate to confirm remaining 25 judges amid Arkansas senator friction

Trump says deportation push hasn’t put ‘same pressure’ on farm workers, hotel staff: ‘Not even close’

Red counties with data center projects swung away from GOP in midterms, analysis finds

Trump DOJ shores up anti-abortion groups’ support amid bid to salvage $1.8 billion Planned Parenthood lawsuit

Official Who Waged War on DEI Out at DOJ

NTSB recovers cockpit voice recorder from Learjet crash site in Florida

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”